Unknown

Dataset Information

0

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.


ABSTRACT: RNA vaccines have demonstrated efficacy against SARS-CoV-2 in humans, and the technology is being leveraged for rapid emergency response. In this report, we assessed immunogenicity and, for the first time, toxicity, biodistribution, and protective efficacy in preclinical models of a two-dose self-amplifying messenger RNA (SAM) vaccine, encoding a prefusion-stabilized spike antigen of SARS-CoV-2 Wuhan-Hu-1 strain and delivered by lipid nanoparticles (LNPs). In mice, one immunization with the SAM vaccine elicited a robust spike-specific antibody response, which was further boosted by a second immunization, and effectively neutralized the matched SARS-CoV-2 Wuhan strain as well as B.1.1.7 (Alpha), B.1.351 (Beta) and B.1.617.2 (Delta) variants. High frequencies of spike-specific germinal center B, Th0/Th1 CD4, and CD8 T cell responses were observed in mice. Local tolerance, potential systemic toxicity, and biodistribution of the vaccine were characterized in rats. In hamsters, the vaccine candidate was well-tolerated, markedly reduced viral load in the upper and lower airways, and protected animals against disease in a dose-dependent manner, with no evidence of disease enhancement following SARS-CoV-2 challenge. Therefore, the SARS-CoV-2 SAM (LNP) vaccine candidate has a favorable safety profile, elicits robust protective immune responses against multiple SARS-CoV-2 variants, and has been advanced to phase 1 clinical evaluation (NCT04758962).

SUBMITTER: Maruggi G 

PROVIDER: S-EPMC8721936 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6953774 | biostudies-literature
| S-EPMC7921634 | biostudies-literature
| S-EPMC10033289 | biostudies-literature
| S-EPMC9628198 | biostudies-literature
| S-EPMC10024013 | biostudies-literature
| S-EPMC5555299 | biostudies-other
| S-EPMC8473206 | biostudies-literature
| S-EPMC3142939 | biostudies-literature
| S-EPMC2864737 | biostudies-literature
| S-EPMC4702536 | biostudies-literature